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FOLLICULAR BIOLOGYAS MICROCOSM OF
CUTANEOUS BIOLOGY
The interests of dermatologists and skin biologists have invari-
ably included hair as a target of investigation. Seventy years
ago, Andrews devoted twenty of 1000 pages to hair abnormalities
in the popular textbook ‘Diseases of the Skin’ (Andrews,
GC: Disease of the Skin, W.B. Saunders, Philadelphia, 1932).
Major portions of these twenty pages were devoted to genetic
abnormalities, alopecia areata, scarring alopecias, and hypertri-
chosis (including a large section on hair depilation). Over the
ensuing seventy years, much has changed, but the diseases have
not. During this time, the discipline of dermatology has
developed a scienti¢c base, a base in which concerns such as stem
cells, mesenchymal^epithelial interaction, and molecular genetics
have come to dominate the scienti¢c landscape. Importantly,
research on hair has participated in this process, even to the
extent that hair biology may be seen as a microcosm of skin
biology in general. Much of the recent progress was discussed
at the International Hair Workshop which took place on
June 12^15, 2001 in Tokyo Japan. This special issue of the Journal
of Investigative Dermatology Proceedings serves as a record of the
progress revealed in that workshop. To provoke interest, we
emphasize below several of the developments that typify that
progress.
BIOCHEMICAL MECHANISMS AND HAIR PHYSIOLOGY
Modulation of gene expression by steroid hormones Know-
ledge about the roles of steroid hormones in the development and
homeostasis of skin remains in its infancy. Some of the most
complete knowledge is about hormonal e¡ects on the pilosebac-
eous apparatus. McPhaul presented contemporary information
about the factors that mediate and modulate androgen action. In
fact, androgens a¡ect a wide range of processes during embryo-
genesis and in adult skin. In mammals, although a number of
steroids can be shown to exert androgenic e¡ects using in vitro
and in vivo assays, testosterone and its reduced metabolite, 50 -di-
hydrotestosterone are thought to represent the principal physiolo-
gic androgens. At present, a body of increasingly detailed
information is available concerning the mechanisms by which
nuclear receptors, such as the androgen receptor, regulate the ac-
tivity of target genes. Such experiments have identi¢ed a host of
molecules capable of modulating the activation or repression of
genes by members of the nuclear receptor family. In parallel,
other experiments have demonstrated the importance of andro-
gen metabolism for speci¢c cell lineages. Knowledge about the
contribution of these in£uences to the regulation of genes by an-
drogens in normal physiology and in disease states is in only its
earliest stages.
Biochemistry and the development of ¢nasteride Shapiro
and Kaufman report on the use of ¢nasteride in treating male-
pattern alopecia. This molecule was the ¢rst highly speci¢c inhi-
bitor of human type 2 50 -reductase developed for clinical use. Ac-
cumulated data from multicenter clinical trials have established
¢nasteride’s importance as a treatment for men with androgen-
dependent alopecia. Its e¡ectiveness has prompted the develop-
ment of other inhibitors of 50 -reductase, as well as research other
modulators of androgen action in skin.
STEM CELLS
Hair follicle stem cells Headed by Lavker, the workshop on
hair follicle stem cells brought together investigators who have
used a variety of approaches to understand the biology of follicu-
lar epithelial stem cells and the role these cells may play in regu-
lating the hair cycle. One of the main concepts to emerge in
workshop discussion was that follicular epithelial stem cells are
multipotent, capable of giving rise not only to all the cell types
of the hair, but also to the epidermis and the sebaceous gland.
Furthermore, such multipotent stem cells may represent the ulti-
mate epidermal stem cell.With respect to their location, immu-
nohistochemical and ultrastructural data were presented
indicating that cells with stem cell attributes were localized to
the prominent bulge region of developing human fetal hair folli-
cles. Finally, a new notion was put forth concerning the roles that
bulge-located stem cells and hair germ cells may play in regulat-
ing the hair cycle.
Negative selection for hair follicle stem cells Matic and
Simon investigated whether connexin 43 (Cx43), a gap junction
protein present in human epidermis and mouse hair follicles,
might serve as a negative marker for keratinocyte stem cells. Ex-
periments carried out in mouse pelage and vibrissae hair follicles
demonstrated that most of the slowly-cycling cells, detected as
label-retaining cells, do not express Cx43. In humans, cells with
undetectable levels of Cx43 are found in the epidermal basal layer
of neonatal foreskin, and in the follicular bulge region. About
10% of the basal keratinocytes are Cx43 negative, as determined
by £ow cytometry. These cells are uniformly small and low in
granularity, suggesting that presumptive keratinocyte stem cells
can be identi¢ed and separated based on Cx43 expression.
ANIMAL MODELS AND IN VITRO MODELS
Epithelial^mesenchymal interactions Randall and collea-
gues reviewed the utility of animal models and in vitro models.
Botchkarev and Kishimoto reviewed the importance of epithe-
lial^mesenchymal interactions, which play pivotal roles in the
morphogenesis of many organs and various types of appendages.
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During hair follicle development, extensive interaction between
the two embryologically disparate compartments leads to forma-
tion of the hair shaft-producing mini-organ that shows cyclic ac-
tivity during postnatal life with periods of active growth,
involution and resting. During the hair cycle, the epithelium
and the mesenchyme are regulated by a distinct set of molecular
signals that are unique for every distinct phase of the hair cycle. In
telogen hair follicles, epithelial^mesenchymal interactions are
characterized by a predominance of inhibitory signals that retain
the hair follicle in a quiescent state. During anagen, a large vari-
ety of growth stimulatory pathways are activated in the epithe-
lium and in the mesenchyme, the coordination of which are
essential for proper hair ¢ber formation. During catagen, the ter-
mination of anagen-speci¢c signaling interactions between the
epithelium and the mesenchyme leads to apoptosis in the hair fol-
licle epithelium, while activation of selected signaling pathways
promotes the transition of the dermal papilla into a quiescent
state. Further progress in this area of research will hopefully lead
to the development of new drugs for the treatment of hair
growth disorders.
Mesenchyme Tobin reviewed issues concerning the plasticity
of hair follicle mesenchyme during the growth cycle. The nature
of the relationship between mesenchyme and epithelium is lar-
gely set during hair follicle morphogenesis, but it is dramatically
revisited in the adult during the unique tissue remodeling events
required for hair follicle cycling. Hair follicle mesenchyme is
widely believed to consist of very stable cell populations, whereas
new data from mice indicate that follicular papilla cell number
increases during anagen and that this increase is driven primarily
by cell proliferation in the proximal connective tissue sheath.
Maximal follicular papilla cell numbers appear to be required
only for the early part of anagen, and soon thereafter cells are
‘lost’ from the follicular papilla, starting during full anagen and
continuing through to complete hair follicle involution (catagen).
The fate of connective tissue/dermal sheath cells during and after
hair follicle regression has been a major gap in our understanding
of hair cycle-dependent ¢broblast dynamics. Plasticity of the FP
and CTS is likely to be a critical element not only for hair cycle
control, but also for hair follicle transformations from vellus-to-
terminal and terminal-to-vellus. Alterations in follicular papilla
cell number lie at the heart of any attempt to explain clinically
important increases and decreases in hair ¢ber size. The cycling
hair follicle o¡ers a very instructive model for studying mesench-
ymal dynamics of specialized ¢broblasts with morphogenic
properties.
ALOPECIA AREATA HAS LESSONS ABOUT
AUTOIMMUNE SKIN DISEASE
McElwee and colleagues review recent experiences with the ex-
perimental autoimmune rodent models to determine its genetic
basis and to understand mechanisms of disease initiation and pro-
gression. Current research suggests a self contained disease cycle
that involves four immunoregulatory events: (1) Failure of the
putative hair follicle immune privilege during anagen with expo-
sure of follicular epitopes to the immune system. (2) Presentation
of epitopes, co-stimulation, and activation of responsive lympho-
cytes by antigen presenting cells. (3) Migration of activated in-
£ammatory cells into hair follicles, and (4) A disruptive action of
the in£ammatory cells within hair follicles. In microcosm, this is
the mechanism of many other autoimmune skin diseases.
Treatment of alopecia areata may be based on immune inter-
vention. Freyschmidt-Paul and her colleagues addressed the futi-
lity of many conventional treatments for alopecia areata,
proposing that possible future therapeutic approaches focus on
immunomodulatory agents such as TGF-b and IL-10; inhibition
of apoptosis mediated by the Fas-FasL system; inhibition of
the lymphocyte homing receptor CD44v10; and induction of
tolerance. Liren Tang and colleagues have already begun to test
the impact of conventional therapeutic modalities on cytokines
and signal transduction pathways in a rodent model of alopecia
areata. To test whether immune cytokines might be modulated
by anthralin, an RNase protection assay (RPA) and a real time
polymerase chain reaction (PCR) were performed to compare
their expression between anthralin-treated and control skins.
These experiments showed that expression of proin£ammatory
cytokinesTNF-a and IFN-? was inhibited by anthralin, while ex-
pression of IL-1a and their receptor antagonist, IL-1R, and im-
munosuppressive IL-10 were stimulated by anthralin. Tsuji and
colleagues observed in work based on the role of TGF- in alo-
pecia areata that a novel plant extract would e¡ectively suppress
TGF- action. They con¢rmed that the extract has a potential to
promote hair elongation in the organ culture system.Their results
suggest that the induction of catagen by TGF- is mediated via
activation of caspases and that a suppressor of TGF- could be
e¡ective in preventing male pattern baldness.
Lessons from Fas-de¢cient and FasL-de¢cient mice Freysch-
midt-Paul and colleagues studied alopecia areata to elucidate
whether the Fas-FasL pathway is of pathogenic signi¢cance in
AA using exchanged skin grafts. Skin-grafts from control mice
developed hair loss, whereas Fas-de¢cient and FasL-de¢cient
skin-grafts were spared from signi¢cant hair loss. The results sug-
gest that the Fas/FasL pathway plays an important pathogenic role
in AA.
SCARRING ALOPECIAS
Olsen and her colleagues reviewed di⁄culties in developing a
nosology for the scarring alopecias. The discussion began with
the assertion that progress in understanding these disorders
has been stymied by the lack of clear diagnostic criteria for the
current terms used to describe various hair loss entities. Based
on a workshop held earlier at Duke University, they have devel-
oped a preliminary system for classifying the entities that make
up the scarring alopecias. This classi¢cation should be of consid-
erable use to clinical investigators as they attempt to address me-
chanisms of the various diseases that make up the scarring
alopecias.
ANDROGENETIC ALOPECIA
Price reviewed the background of androgenetic alopecia in wo-
men. Androgenetic alopecia (AGA), also known in women as fe-
male pattern hair loss, is caused by androgens in genetically
susceptible women and men. The thinning begins between ages
12 and 40 years, the inheritance pattern is polygenic, and the in-
cidence is the same as in men. Both young women and young
men with AGA have higher levels of 5a reductase and androgen
receptor in frontal hair follicles compared to occipital follicles. At
the same time, young women have much higher levels of cyto-
chrome p-450 aromatase in frontal follicles than men who have
minimal aromatase, and women have even higher aromatase le-
vels in occipital follicles. The diagnosis of AGA in women is sup-
ported by early age of onset, the pattern of increased thinning
over the frontal/parietal scalp with greater density over the occi-
pital scalp, retention of the frontal hairline, and the presence of
miniaturized hairs. Most women with AGA have normal menses
and pregnancies. Topical minoxidil solution is the only drug
available for promoting hair growth in women with AGA, as ef-
¢cacy has been shown in double-blind studies using hair counts
and hair weight.
Inui and colleagues presented work on the identi¢cation of an-
drogen-inducible TGF-1 derived from dermal papilla cells as a
mediator in androgenetic alopecia. Working with a coculture
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model of human dermal papilla cells from androgenetic alopecia
and normal keratinocytes they transiently transfected the
androgen receptor expression vector into the dermal papilla cells.
Exogenous androgen inhibited the growth of keratinocytes
through a di¡usible growth suppressive factor, most likelyTGF-
1 which was released into the medium. Moreover, neutralizing
anti-TGF-1antibodies reversed the inhibition of KC prolifera-
tion. Thus, they have suggest that androgen-inducible TGF-1
derived from dermal papilla cells mediates hair growth suppres-
sion in androgenetic alopecia.
MEASURING HAIRS AND HAIRGROWTH
Ho¡mann emphasized the need for a sensitive tool to monitor
hair loss and treatment responses. Brie£y stated, such a method
must be able to analyze the biological parameters of hair growth,
which are: hair density, hair diameter, growth rate, anagen/telo-
gen ratios. He presented the TrichoScan as a method that com-
bines epiluminescence microscopy (ELM) with automatic digital
image analysis to measure hair in situ. The TrichoScan is able to
analyze all four parameters of hair growth with a so called intra-
class correlation of approx. 91% within the same TrichoScan op-
erator and an intraclass correlation of approx. 97% for di¡erent
TrichoScan operators. The application of the technique is demon-
strated by comparing the hair parameters in individuals without
apparent hair loss, men with untreated AGA, and men after treat-
ment with ¢nasteride (1 mg/day). He was able to detect a signi¢-
cant increase in hair counts and cumulative hair thickness 3 and 6
months after treatment. Use of the TrichoScan appears to have
many advantages.
Ueki and colleagues reported on hair growth patterns of one
hundred one Japanese female subjects with di¡use, chronic hair
loss and ¢fty-eight healthy Japanese female volunteers were cate-
gorized into sub-groups using non- invasive quantitative meth-
ods after determining the key parameters of hair growth. The
Phototrichogramwas performed at 0 and 48 h after clipping hairs
in the parietal region of the scalp. Shaft diameters of the excised
hairs were then measured. Multiple regression analysis indicated
that hair densities, hair diameters, short hair ratios and hair
growth rates, but not anagen hair ratios, were signi¢cant, in or-
der of decreasing importance, for grading female di¡use alopecia.
Using cluster analysis, hair growth patterns among subjects com-
plaining of di¡use hair loss were divided into six abnormal
groups (N¼ 60), two borderline groups (N¼ 21) and one normal
group (N¼ 20). Hair patterns showing a decrease in hair
density but without vellus hair change, emerged as the most
prevalent and distinct pattern of chronic di¡use hair loss among
the Japanese female subjects. The phototrichogram, combined
with the measurement of hair diameters, appears to be an accurate
tool for assessing hair growth patterns, especially in detecting
the slight changes indicative of the early phase of di¡use
alopecia.
CHARACTERIZATION OF HUMAN KERATIN
ASSOCIATED PROTEIN (HKAP) 1 FAMILY MEMBERS
Shimomura reported that keratin-associated proteins (KAPs) are
involved in the formation of the cross-linked network of the ker-
atin-intermediate ¢lament proteins that support hair ¢bers. In re-
cent years, several KAP genes have been identi¢ed and become
an attractive topic in hair research. These investigators had iso-
lated two cDNAs encoding novel members of the human KAP1
family, hKAP1.6 and hKAP1.7, and described their expression in
the hair follicle by RNA in situ hybridization. A comparison of
hKAP1.6 and hKAP1.7 with other human KAP1 members re-
vealed that KAP1 proteins are fundamentally composed of ¢ve
distinct domains, and that they can be classi¢ed primarily by a
striking variation in double cysteine-containing pentapeptide re-
peats in the repetitive I domain. The sum of the data analyzed
suggests that human KAP1 family genes may have arisen mainly
through gene duplication of the cysteine-repeat motifs during
evolution.
FATE OF MELANOCYTES DURING DEVELOPMENT OF
THE HAIR FOLLICLE PIGMENTARY UNIT
Botchkareva reported that during hair follicle morphogenesis,
melanocyte precursors migrate into developing hair follicles and
give rise to di¡erentiated melanocytes that actively produce and
transport pigment into the keratinocytes that form the hair shaft.
However, patterns of melanocyte proliferation and di¡erentiation
during formation of the hair pigmentation unit remain to be elu-
cidated. Using multi-color confocal microscopy and double im-
muno£uorescence of melanogenic proteins [tyrosinase-related
proteins 1 and 2 (TRP1/TRP2), tyrosinase] and the proliferative
marker Ki67, these investigators studied melanocyte development
in C57BL/6 mouse embryonic hair follicles. Proliferating mela-
nocyte precursors (TRP2/Ki67þ cells) was seen in the hair folli-
cles at stages 1^2 of morphogenesis, as follicular invagination
begins. In stage 3^4 hair follicles, the majority of intrafollicular
melanocytes remained TRP2þ and Ki67þ, while some located
adjacent to the forming dermal papilla began to express TRP1, an
early marker of di¡erentiation. Melanin granules appeared in
stage 5 hair follicles coincident with tyrosinase expression in
non-proliferating TRP2þ /TRP1þ melanocytes. Stage 6^8 hair
follicles, those actively producing hair, showed non- proliferating
TRP2þ melanocytes in the bulge area,TRP2þ /TRP1þ mel-
anocytes in the outer root sheath, and TRP2þ /TRP1þ/
tyrosinaseþ melanocytes above the dermal papilla. These data
suggested that melanocyte precursor cells proliferate extensively
at the onset of follicle development. Progeny of these cells mi-
grate down the developing follicle, di¡erentiating further until
reaching the area immediately above the dermal papilla, where
fully di¡erentiated non-proliferative melanin-producing melano-
cytes persist, contributing pigment to the growing hair shaft.
IN THIS ISSUE ixVOL. 8, NO. 1 JUNE 2003
